Back
Viking Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
VKTX
Viking Therapeutics
Last Price:
$28.40
Seasonality Move:
12.7%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight selling pressure.
Viking Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.67 | Buy |
20-day SMA: | 27.21 | Buy |
50-day SMA: | 26.49 | Buy |
200-day SMA: | 45.25 | Sell |
8-day EMA: | 27.7 | Buy |
20-day EMA: | 27.15 | Buy |
50-day EMA: | 27.77 | Buy |
200-day EMA: | 38.66 | Sell |
Viking Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.53 | Buy |
Relative Strength Index (14 RSI): | 56.12 | Buy |
Chaikin Money Flow: | -354304 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.43 - 28.51) | Buy |
Bollinger Bands (100): | (24.87 - 36.21) | Sell |
Viking Therapeutics Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 28.43 while VKTX 8-day simple moving average is 27.67, which is a Buy signal.
-
The stock price of VKTX is 28.43 while Viking Therapeutics 20-day SMA is 27.21, which makes it a Buy.
-
Viking Therapeutics 50-day simple moving average is 26.49 while VKTX share price is 28.43, making it a Buy technically.
-
VKTX stock price is 28.43 and Viking Therapeutics 200-day simple moving average is 45.25, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Buy
53
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a BuyThe current Viking Therapeutics [VKTX] share price is $28.43. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Viking Therapeutics Stock Info
Market Cap:
3.2B
Price in USD:
28.43
Share Volume:
3.2M
Viking Therapeutics 52-Week Range
52-Week High:
81.73
52-Week Low:
18.92
Buy
53
Viking Therapeutics (VKTX)
is a Buy
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?The Viking Therapeutics stock price is 28.43 USD today.
-
Will VKTX stock go up or go down?Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viking Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is not overvalued.
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 28.43 while VKTX 8-day exponential moving average is 27.70, which is a Buy signal.
-
The stock price of VKTX is 28.43 while Viking Therapeutics 20-day EMA is 27.15, which makes it a Buy.
-
Viking Therapeutics 50-day exponential moving average is 27.77 while VKTX share price is 28.43, making it a Buy technically.
-
VKTX stock price is 28.43 and Viking Therapeutics 200-day simple moving average is 38.66, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.28 per share, a decrease this year of $0.88 per share, and a decrease next year of $0.64 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
-
VKTX Moving Average Covergence Divergence (MACD) indicator is 0.53, suggesting Viking Therapeutics is a Buy
-
Viking Therapeutics Relative Strength Index (RSI) is 56.12, which suggest Viking Therapeutics is overbought
-
The Bollinger Bands (25) for Viking Therapeutics is (24.43 - 28.51), which suggest Viking Therapeutics is a Sell
-
The Bollinger Bands (100) for Viking Therapeutics is (24.87 - 36.21), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.